Managed Care Weekly Digest
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Sepsis
New sepsis study findings have been reported by researchers at Kaohsiung Medical University
June 15th, 2009
In this recent report published in the International Journal of Clinical Pharmacology and Therapeutics, researchers in Kaohsiung, Taiwan conducted a study "To assess the health and cost outcomes of pharmacist intervention versus non-intervention in activated protein C (drotrecogin alpha) therapy for patients with severe sepsis. This is a retrospective study." "We reviewed the medical records of patients aged 18 years and older who were admitted to our hospital for severe sepsis from January 1, 2003 to December 31, 2007. Only patients who are prescribed activated protein C for the treatment of severe sepsis according to the reimbursement criteria can be reimbursed...
Source: Managed Care Weekly Digest (2009-06-15)
|
